Everett leads the commercial organization at Cognito Therapeutics, which comprises marketing, sales, market access, and health economics. Prior to Cognito, Everett was Chief Commercial Officer at AppliedVR where he led the global launch and commercialization of their breakthrough designated chronic pain virtual reality therapeutic. He oversaw the launch readiness, marketing, sales, health economic, reimbursement and payer strategies for AppliedVR’s acute pain suite of products. During his tenure, Everett helped close AVR’s $29M series A and broker commercial licensing and development deals with multiple pharmaceutical companies. Prior to AppliedVR, Everett served as the VP of Market Access, Reimbursement, and GovernmentAffairs at Pear Therapeutics where he launched the first breakthrough digital therapeutic to the payer market, acted as the Commercial representative for the $50M series B diligence, and helped broker the licensing of multiple assets to Novartis/Sandoz. In his personal time, Everett enjoys learning how to cook new meals and hiking in the White Mountains with his family.